Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid

Dermatology. 2017;233(5):401-403. doi: 10.1159/000480498. Epub 2017 Oct 18.

Authors

Clara Schaffer¹, Thierry Buclin, Francois R Jornayvaz, Simone Cazzaniga, Luca Borradori, Michel Gilliet, Laurence Feldmeyer

Affiliation

¹ Department of Dermatology and Venereology, Lausanne University Hospital Centre, Lausanne, Switzerland.

PMID: 29040970
DOI: 10.1159/000480498

No abstract available

Publication types

Letter

MeSH terms

Adamantane / therapeutic use
Aged
Aged, 80 and over
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
Female
Humans
Male
Pemphigoid, Bullous / drug therapy*
Pyrrolidines / therapeutic use

Substances

Dipeptidyl-Peptidase IV Inhibitors
Pyrrolidines
Adamantane